FAQ

Tuberculosis, Multidrug-Resistant

Known as: MDR-TB, multidrug resistant tuberculosis, Multidrug-Resistant TB 
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance… (More)

Topic mentions per year

Topic mentions per year

1945-2018
020040019452017

Related topics

Related topics

13 relations
Antitubercular AgentsDrug Resistance, BacterialDrug Resistance, MicrobialIn Blood
(More)

Broader (1)

Tuberculosis, Drug-Resistant

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Tuberculosis, Multidrug-Resistant
Tuberculosis
radiotherapeutic
Multi-Drug Resistance
prevention & control
Microbiological

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Delamanid for multidrug-resistant pulmonary tuberculosis.
BACKGROUND Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
BACKGROUND The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.
RATIONALE Based on expert opinion, the global guidelines for management of multidrug-resistant tuberculosis impose lengthy and… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosis.
BACKGROUND The diarylquinoline TMC207 offers a new mechanism of antituberculosis action by inhibiting mycobacterial ATP synthase… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
RATIONALE The dual challenges to tuberculosis (TB) control of HIV infection and multidrug resistance are particularly pressing in… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
Mathematical models have recently been used to predict the future burden of multidrug-resistant tuberculosis (MDRTB). These… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.
Multidrug-resistant tuberculosis, a disease caused by Mycobacterium tuberculosis strains that are resistant at least to rifampin… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
Control of tuberculosis is threatened by widespread emergence of drug resistance in Mycobacterium tuberculosis. Understanding the… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
BACKGROUND In the United States there have been recent outbreaks of multidrug-resistant tuberculosis. These outbreaks have… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.
BACKGROUND Since 1990 several clusters of multidrug-resistant tuberculosis have been identified among hospitalized patients with… (More)
Is this relevant?